Sign in
4

Changes in Ownership

IONIS PHARMACEUTICALS INC Filed Acc 0000874015-24-000073

EVP, Chief Scientific Officer sold 6,745 shares at $50.42 ($340,063)

  • EVP, Chief Scientific Officer acquired 18,314 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

BENNETT C FRANK · EVP, Chief Scientific Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-01-16 Exercise or conversion : show line 1 in the form +18,314 84,068 D
2024-01-17 Sale : show line 2 in the form −6,745 $50.42 $340,063 77,323 D
Open-market sales · 6,745 sh · avg $50.42 · $340,063

Table II: Derivative

1 line
Date Transaction Shares Exercise Underlying Owned after D/I
2024-01-16 Exercise or conversion : show line 3 in the form Restricted Stock Unit −18,314 $0.00 18,314 23,500 D
Loading xslF345X05/edgardoc.xml…